Results 301 to 310 of about 321,595 (358)

A Portable One-Tube Assay Integrating RT-RPA and CRISPR/Cas12a for Rapid Visual Detection of Eurasian Avian-like H1N1 Swine Influenza Virus in the Field. [PDF]

Viruses
Tian C, Feng L, Zhou X, Huang K, Wang F, Luo R, Meng F, Yang H, Qiao C, Wang X, Shi J, Chen Y.   +11 more
europepmc   +1 more source

DOTAP-Based Hybrid Nanostructured Lipid Carriers for CRISPR-Cas9 RNP Delivery Targeting <i>TGFB1</i> in Diabetic Nephropathy. [PDF]

Pharmaceutics
Jummah N, Kamila HS, Satrialdi, Artarini AA, Sadaqa E, Anindyajati, Mudhakir D.   +6 more
europepmc   +1 more source

Searching for a HIV-1 Cure. [PDF]

Theranostics
Zhang C, Chaudhary BN, Ali MU, Heser MG, Patel SS, Du X, Dey SS, Mosley RL, Panja S, Gendelman HE.   +9 more
europepmc   +1 more source

Callus and endosperm green fluorescence reporter-assisted selection system in maize CRISPR/Cas9 gene editing. [PDF]

BMC Plant Biol
Ge L, Li W, Dou Y, Ma Y, Sun M, Chen X, Feng X, Li Y, Yu Q.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CRISPR

2021
The gene scissors CRISPR/Cas9 has revolutionized genetic engineering in many ways. The technology promises to precisely cut and change gene segments from humans, animals and plants. But how should we deal with a technology that could irreversible change the genetic make-up? A public debate is of utmost importance to answer what science is allowed to do.
Tao Xu, Megan L. Kempher, Xuanyu Tao, Aifen Zhou, Jizhong Zhou   +4 more
  +6 more sources

Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants

Nature Reviews Microbiology, 2019
Kira S Makarova, Yuri I Wolf, Jaime Iranzo   +2 more
exaly   +2 more sources

Multiplex Genome Engineering Using CRISPR/Cas Systems

Science, 2013
Le Cong, F Ann Ran, Shuailiang Lin
exaly   +2 more sources